✦ LIBER ✦

Optimization of GPR40 Agonists for Type 2 Diabetes

✍ Scribed by Liu, Jiwen (Jim); Wang, Yingcai; Ma, Zhihua; Schmitt, Mike; Zhu, Liusheng; Brown, Sean P.; Dransfield, Paul J.; Sun, Ying; Sharma, Rajiv; Guo, Qi; Zhuang, Run; Zhang, Jane; Luo, Jian; Tonn, George R.; Wong, Simon; Swaminath, Gayathri; Medina, Julio C.; Lin, Daniel C.-H.; Houze, Jonathan B.

Book ID: 125489447
Publisher: American Chemical Society
Year: 2014
Tongue: English
Weight: 312 KB
Volume: 5
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml400501x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The therapeutic potential of GPR119 agon

The therapeutic potential of GPR119 agonists for type 2 diabetes

✍ Ohishi, Takahide; Yoshida, Shigeru 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 257 KB

Novel GPR119 agonist HD0471042 attenuate

Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus

✍ Ha, Tae-Young; Kim, Young-Seok; Kim, Chun Hwa; Choi, Hyo-Sun; Yang, Jin; Park, S 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 468 KB

Design of potent and selective GPR119 ag

Design of potent and selective GPR119 agonists for type II diabetes

✍ Jason W. Szewczyk; John Acton; Alan D. Adams; Gary Chicchi; Stanley Freeman; And 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Screening of the Merck sample collection identified compound 1 as a weakly potent GPR119 agonist (hEC(50)=3600 nM). Dual termini optimization of 1 led to compound 36 having improved potency, selectivity, and formulation profile, however, modest physical properties (PP) hindered its utility. Design o

Activation of GPR40 as a Therapeutic Tar

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes

✍ Burant, C. F. 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 151 KB

Modulators of GPR40 as Treatment for Dia

Modulators of GPR40 as Treatment for Diabetes

✍ Abdel-Magid, Ahmed F. 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 249 KB

ChemInform Abstract: Design of Potent an

ChemInform Abstract: Design of Potent and Selective GPR119 Agonists for Type II Diabetes.

✍ Jason W. Szewczyk; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 12 KB

## Abstract Dual termini optimization of a bis‐piperidine‐based GPR119 agonist affords an analogue possessing improved potency, selectivity, and formulation profile, but modest physical properties.